JP2016530248A5 - - Google Patents

Download PDF

Info

Publication number
JP2016530248A5
JP2016530248A5 JP2016530446A JP2016530446A JP2016530248A5 JP 2016530248 A5 JP2016530248 A5 JP 2016530248A5 JP 2016530446 A JP2016530446 A JP 2016530446A JP 2016530446 A JP2016530446 A JP 2016530446A JP 2016530248 A5 JP2016530248 A5 JP 2016530248A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
formula
optionally
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016530446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016530248A (ja
JP6208352B2 (ja
Filing date
Publication date
Priority claimed from GBGB1313465.5A external-priority patent/GB201313465D0/en
Application filed filed Critical
Publication of JP2016530248A publication Critical patent/JP2016530248A/ja
Publication of JP2016530248A5 publication Critical patent/JP2016530248A5/ja
Application granted granted Critical
Publication of JP6208352B2 publication Critical patent/JP6208352B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016530446A 2013-07-29 2014-07-24 ニコチンアミドリボシドおよびその誘導体を調製する方法 Active JP6208352B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1313465.5A GB201313465D0 (en) 2013-07-29 2013-07-29 Methods of preparing nicotinamide riboside and derivatives thereof
GB1313465.5 2013-07-29
PCT/EP2014/065971 WO2015014722A1 (en) 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof

Publications (3)

Publication Number Publication Date
JP2016530248A JP2016530248A (ja) 2016-09-29
JP2016530248A5 true JP2016530248A5 (cg-RX-API-DMAC7.html) 2017-09-07
JP6208352B2 JP6208352B2 (ja) 2017-10-04

Family

ID=49167061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016530446A Active JP6208352B2 (ja) 2013-07-29 2014-07-24 ニコチンアミドリボシドおよびその誘導体を調製する方法

Country Status (14)

Country Link
US (6) US10000519B2 (cg-RX-API-DMAC7.html)
EP (2) EP3027635B1 (cg-RX-API-DMAC7.html)
JP (1) JP6208352B2 (cg-RX-API-DMAC7.html)
KR (2) KR102414886B1 (cg-RX-API-DMAC7.html)
CN (2) CN105636973B (cg-RX-API-DMAC7.html)
AU (4) AU2014298629B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016001774B1 (cg-RX-API-DMAC7.html)
CA (2) CA3192957A1 (cg-RX-API-DMAC7.html)
ES (1) ES2652654T3 (cg-RX-API-DMAC7.html)
GB (1) GB201313465D0 (cg-RX-API-DMAC7.html)
HK (1) HK1255037A1 (cg-RX-API-DMAC7.html)
MX (1) MX349969B (cg-RX-API-DMAC7.html)
WO (1) WO2015014722A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201802315B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
US10316054B2 (en) 2014-06-02 2019-06-11 Glaxosmithkline Intellectual Property (No. 2) Limited Preparation and use of crystalline beta-D-nicotinamide riboside
JP6559713B2 (ja) * 2014-06-06 2019-08-14 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited ニコチンアミドリボシド類似体ならびにその医薬組成物および使用
CN106715454B (zh) * 2014-07-24 2020-06-16 格雷斯公司 烟酰胺核苷的结晶形式
FI3268379T3 (fi) * 2015-03-09 2023-12-15 Grace W R & Co Nikotiiniamidiribosidin kiteinen muoto
BR112017019696A2 (pt) * 2015-03-16 2018-09-04 ChromaDex Inc. composto e usos de um composto
WO2017011788A1 (en) 2015-07-15 2017-01-19 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
KR102354784B1 (ko) 2015-08-05 2022-01-25 메트로 인터내셔널 바이오테크 엘엘씨 니코틴아미드 모노뉴클레오티드 유도체 및 그 용도
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
WO2017079195A1 (en) * 2015-11-02 2017-05-11 Mitobridge, Inc. Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
WO2017145151A1 (en) 2016-02-23 2017-08-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Process for preparation of nicotinamide riboside (nr) and cosmetic composition comprising (nr and a phosphate-binding agent
AU2017232930B2 (en) 2016-03-16 2021-03-25 ChromaDex Inc. B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
NZ747693A (en) 2016-04-20 2023-07-28 Chromadex Inc Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
GB2553001A (en) * 2016-08-19 2018-02-21 The Queen's Univ Of Belfast Lactone intermediates of nicotinamide riboside and nicotinate riboside
WO2018089830A1 (en) 2016-11-11 2018-05-17 The Queen's University Of Belfast Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
BR112019010607B1 (pt) 2016-11-29 2023-10-31 University Of Iowa Research Foundation Uso de precursores de nad e composição compreendendo os referidos precursores
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
EP3642214A2 (en) 2017-06-19 2020-04-29 Gangadhara Ganapati Nicotinamide riboside derivatives and their uses
JP2020526511A (ja) * 2017-06-30 2020-08-31 エリジウム・ヘルス・インコーポレイテッド ニコチンアミドリボシドの合成方法
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
WO2019122084A1 (en) 2017-12-22 2019-06-27 Stemtek Therapeutics, S.L. Process for the preparation of nicotinamide riboside chloride derivatives
WO2019152416A1 (en) 2018-01-30 2019-08-08 Metro International Biotech, Llc Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
CN110283221A (zh) * 2018-03-19 2019-09-27 药源药物化学(上海)有限公司 杂环化合物的制备和纯化方法
CN110452277A (zh) * 2018-05-07 2019-11-15 明特奇点医疗科技(成都)有限公司 一种烟酰胺核糖的制备方法
AU2019274524A1 (en) * 2018-05-22 2021-01-07 Roland Dolle Amino acid salts of nicotinic acid ribosides as anti-aging agents
US20210267251A1 (en) * 2018-06-21 2021-09-02 Societe Des Produits Nestle S.A. Compositions and methods using a nicotinamide adenine dinucleotide (nad+) precursor and at least one ketone or ketone precursor
CN108774278A (zh) * 2018-09-10 2018-11-09 张洪喜 一种制备尼克酰胺核苷盐的方法
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
US11833167B2 (en) 2018-12-17 2023-12-05 Mitopower Llc Nicotinyl riboside compounds and their uses
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
US10618927B1 (en) 2019-03-22 2020-04-14 Metro International Biotech, Llc Compositions and methods for modulation of nicotinamide adenine dinucleotide
CA3148300A1 (en) 2019-07-19 2021-01-28 Biosynth Ag Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
WO2021030551A1 (en) * 2019-08-14 2021-02-18 Metro International Biotech, Llc Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide
CN110642897B (zh) * 2019-09-27 2021-04-06 武汉一若生物材料有限公司 一种β-烟酰胺核糖氯化物的制备方法
CN110658224B (zh) * 2019-10-15 2022-11-22 中国中医科学院中药研究所 一种氢核磁定量分析技术测定nmn绝对含量的方法
CN111153953A (zh) * 2020-01-07 2020-05-15 杭州洁汉化工有限公司 一种烟酰胺核糖氯化物的高效合成方法
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
CN111647032B (zh) * 2020-06-29 2023-02-24 上海舒泽生物科技研究所 一种β-烟酰胺单核苷酸的合成方法
CN111848710A (zh) * 2020-08-20 2020-10-30 深圳市迪克曼科技开发有限公司 烟酰胺核糖及其还原态、盐的制备方法
WO2022058312A1 (en) * 2020-09-15 2022-03-24 Société des Produits Nestlé S.A. Methods for producing dihydronicotinamide riboside from nicotinamide riboside chloride
CN112851730B (zh) * 2021-01-08 2023-02-21 厦门瑞林药业有限公司 一种nmn中间体nr氯化物合成方法
JP2024517260A (ja) 2021-05-04 2024-04-19 ボーハン アンド カンパニー エーエス ニコチンアミドリボシドクロリド(nrcl)の合成プロセス
IL308577A (en) 2021-05-27 2024-01-01 Metro Int Biotech Llc Crystalline solids of nicotinic acid mononucleotides and their esters and methods for their preparation and use
EP4486751A1 (en) 2022-03-04 2025-01-08 Bohan & Co AS. Process for synthesis of 1,4-dihydronicotinamide riboside (nrh) from nicotinamide-beta-riboside triacetate chloride (nra-cl)
CN116462727A (zh) * 2023-04-23 2023-07-21 安徽瑞邦生物科技有限公司 一种β-烟酰胺核糖氯化物的制备方法
US20240415863A1 (en) * 2023-06-14 2024-12-19 ChromaDex Inc. Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008288A1 (en) * 1991-10-23 1993-04-29 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
US6689760B1 (en) * 2000-07-10 2004-02-10 Enzrel Inc. Anti-mycobacterial compositions
EP3369738B1 (en) * 2005-11-18 2020-05-20 Cornell Research Foundation, Inc. Method for making nicotinoyl ribosides and nicotinamide beta-riboside
US9603862B2 (en) * 2009-12-14 2017-03-28 Cornell University Activation and activators of SIRT5
JP2013522171A (ja) * 2010-03-01 2013-06-13 ミレクシス, インコーポレイテッド 化合物およびその治療用途
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
JP6559713B2 (ja) * 2014-06-06 2019-08-14 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited ニコチンアミドリボシド類似体ならびにその医薬組成物および使用

Similar Documents

Publication Publication Date Title
JP2016530248A5 (cg-RX-API-DMAC7.html)
JP2015533852A5 (cg-RX-API-DMAC7.html)
US20160130208A1 (en) Synthesis of alpha,beta-unsaturated carboxylic acid (meth)acrylates from olefins and co2
CN102351720A (zh) 一种简易高效的氨溴素合成方法
MY166899A (en) Production method for polyamide
CN111233829A (zh) 一种具有光学活性的尼古丁的制备方法
JP2014504599A5 (cg-RX-API-DMAC7.html)
JP2015530985A5 (cg-RX-API-DMAC7.html)
JP4889737B2 (ja) N置換イソチアゾリノン誘導体の製造
JP5552128B2 (ja) 対応する三級アミンのカルボニル化による二級アミドを製造する方法
KR102652211B1 (ko) 이미노디아세트산의 제조방법
CN110950778A (zh) 制备芳族丙二腈的方法和催化剂体系
CN102285937A (zh) 非布索坦的合成方法
JP2008031166A (ja) ボロン酸およびその誘導体の調製方法
JP2020524713A (ja) ラタモキセフのカルボキシル基及びヒドロキシル基の保護基を取り除く方法
CN102796135A (zh) 0,0-二(2-乙基己基)-2-乙基己基膦酸酯的合成方法
JP4822253B2 (ja) 二酸化炭素と水素からギ酸塩の製造方法
CN108586300A (zh) 一种s-碘化丁酰硫代胆碱的合成方法
CN104591938B (zh) 一种医药中间体二芳基甲烷类化合物的合成方法
JP2010511042A5 (cg-RX-API-DMAC7.html)
WO2015033191A1 (en) A process for preparation of (2s, 5r)- sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
CN102276634A (zh) 氮杂卡宾银络合物的制备方法
CN102675197A (zh) 一种制备索拉非尼中间体4-氯-n-甲基吡啶-2-甲酰胺的方法
Xia et al. Construction of Novel Chiral NPN Ligands and the Application in Gold (I)‐Catalyzed Asymmetric Cycloaddition Reactions
KR102500243B1 (ko) 5-(c1~c4 알킬) 테트라졸의 합성방법